Q2 2020 Holdings
Filed 2020-08-05 | 9 holdings | $98.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cabaletta Bio, Inc.(CABA) | COM | 12674W109 | $40.9M | 3,669,263 | 41.4% |
| Arvinas, Inc.(ARVN) | COM | 04335A105 | $33.5M | 1,000,000 | 34.0% |
| Crinetics Pharmaceuticals, Inc.(CRNX) | COM | 22663K107 | $23.9M | 1,362,286 | 24.2% |
| Akouos Inc. | COM | 00973J101 | $103.6K | 4,605,784 | 0.1% |
| Aprea Therapeutics, Inc. | COM | 03836J102 | $85.8K | 2,212,654 | 0.1% |
| Homology Medicines, Inc. | COM | 438083107 | $84.1K | 5,535,919 | 0.1% |
| Ideaya Biosciences, Inc.(IDYA) | COM | 45166A102 | $49.2K | 3,463,066 | 0.0% |
| scPharmaceuticals Inc.(SCPH) | COM | 810648105 | $28.2K | 3,831,474 | 0.0% |
| Cidara Therapeutics, Inc. | COM | 171757107 | $7.4K | 2,006,511 | 0.0% |